Sign In
Buy AMRN
$14.53
+0.0600 (+0.415%)
At Close: Jun 03, 2026
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE
07:05am, Tuesday, 24'th Jun 2025
RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA ® IN EUROPE
Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?
10:56am, Monday, 16'th Jun 2025
From a technical perspective, Amarin Corporation PLC (AMRN) is looking like an interesting pick, as it just reached a key level of support. AMRN's 50-day simple moving average crossed above its 200-da
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
10:41am, Monday, 16'th Jun 2025
Here is how Amarin (AMRN) and GSK (GSK) have performed compared to their sector so far this year.
Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:01pm, Tuesday, 10'th Jun 2025
Amarin (AMRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Best Momentum Stocks to Buy for June 10th
11:00am, Tuesday, 10'th Jun 2025
AMRN, FIX and PATH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 10, 2025.
New Strong Buy Stocks for June 10th
07:51am, Tuesday, 10'th Jun 2025
FIX, GHLD, AMRN, VCISY and NWFL have been added to the Zacks Rank #1 (Strong Buy) List on June 10, 2025.
Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y
01:10pm, Thursday, 08'th May 2025
AMRN reports better-than-expected results for the first quarter of 2025. However, the top and bottom lines decline on a year-over-year basis.
Amarin Corporation plc (AMRN) Q1 2025 Earnings Call Transcript
11:01am, Wednesday, 07'th May 2025
Amarin Corporation plc (NASDAQ:AMRN ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Mark Marmur - Vice President of Corporate Communications and Investor Relations Aaron
Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement
04:15pm, Tuesday, 29'th Apr 2025
-- Nasdaq Compliance Follows ADS Ratio Change to Secure Company's Public Listing -- -- Amarin Remains Focused on Maximizing the Global Value of VASCEPA/VAZKEPA –
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
04:15pm, Monday, 28'th Apr 2025
DUBLIN and BRIDGEWATER, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members
Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
07:30am, Wednesday, 09'th Apr 2025
DUBLIN and BRIDGEWATER, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today confirmed that April 11, 2025 will be the effective date for the Company's previously anno
Amarin Appoints JEC Capital Partners' Michael Torok to Board of Directors
07:30am, Monday, 07'th Apr 2025
DUBLIN, Ireland and BRIDGEWATER, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Michael Torok, Co-Founder and Managing Director of inv
Concerned Shareholder Group Urges Amarin's Board of Directors to Initiate a Strategic Review Following Two Years of Underperformance
12:45pm, Wednesday, 19'th Mar 2025
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok, the Managing Director of JEC Capital Partners (together with certain of their affiliates, the “Concerned Shareholder Group” or “we�
New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology's (ACC) Annual Scientific Session & Expo
07:30am, Wednesday, 19'th Mar 2025
DUBLIN and BRIDGEWATER, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that additional in vitro mechanistic data with eicosapentaenoic acid (EPA) will be
Amarin Corporation plc (AMRN) Q4 2024 Earnings Call Transcript
10:30am, Wednesday, 12'th Mar 2025
Amarin Corporation plc (NASDAQ:AMRN ) Q4 2024 Earnings Conference Call March 12, 2025 8:00 AM ET Company Participants Mark Marmur - Vice President of Corporate Communications and Investor Relations Aa
